Quality assessment of muscle injury classification in sports: a systematic literature review l

SantAnna, João Paulo Cortez de; Almeida, Arací Malagodi de; Pedrinelli, André; Hernandez, Arnaldo José; Fernandes, Tiago Lazzaretti

doi:10.32098/mltj.02.2018.10

Cited by 3 publications

(6 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…►Table 1 shows some of the current classification models. 11 The classification proposed by Mueller-Wohlfarht et al, 8 known as the Munich Consensus, and the system described by Mafulli et al, 16 also consider etiological aspects. These classify muscle injury as direct, caused by contusion or laceration, and indirect, subclassified into functional (nonstructural) or structural.…”

Section: Classificationmentioning

confidence: 99%

“…A ►Tabela 1 mostra alguns dos modelos de classificação existentes atualmente. 11 A classificação proposta por Mueller-Wohlfarht et al por Mafulli et al, 16 consideram também aspectos etiológicos. Estes classificam a lesão muscular como direta, causada por contusão ou laceração, e indireta, subclassificada em funcional (não estrutural) ou estrutural.…”

Section: Mecanismos De Lesãounclassified

“…Apenas nos últimos 10 anos, 5 sistemas diferentes foram publicados. 11 Classicamente, os sistemas descrevem a lesão muscular em 3 diferentes níveis: leves, moderadas e graves (ou graus I, II e III) a partir de avaliação por imagem 12 13 ou dos aspectos clínicos revelados. 14 Novos sistemas estadiam as lesões de forma mais complexa, 8 15 16 utilizando, além das características descritas acima, aspectos relacionados à etiologia e à localização anatômica da lesão.…”

Section: Classificaçãounclassified

“…In the last 10 years only, 5 different systems have been published. 11 Classically, the systems describe muscle injury at 3 different levels, mild, moderate and severe (or grade I, II and III) from imaging evaluation 12 13 or from the clinical aspects revealed. 14 New systems stage the lesions in a more complex way, 8 15 16 using, in addition to the characteristics described above, aspects related to the etiology and anatomical location of the lesion.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Lesão muscular: Fisiopatologia, diagnóstico e tratamento

SantAnna

Pedrinelli

Hernandez

et al. 2022

Rev Bras Ortop (Sao Paulo)

View full text Add to dashboard Cite

ResumoO tecido muscular esquelético possui a maior massa do corpo humano, correspondendo a 45% do peso total. As lesões musculares podem ser causadas por contusões, estiramentos ou lacerações. A atual classificação separa as lesões entre leves, moderadas e graves. Os sinais e sintomas das lesões grau I são edema e desconforto; grau II, perda de função, gap e equimose eventual; grau III, rotura completa, dor intensa e hematoma extenso. O diagnóstico pode ser confirmado por ultrassom (dinâmico e barato, porém examinador-dependente); e ressonância magnética (RM) (maior definição anatômica). A fase inicial do tratamento se resume à proteção, ao repouso, ao uso otimizado do membro afetado e crioterapia. Anti-inflamatórios não hormonais (AINHs), ultrassom terapêutico, fortalecimento e alongamento após a fase inicial e amplitudes de movimento sem dor são utilizados no tratamento clínico. Já o cirúrgico possui indicações precisas: drenagem do hematoma, reinserção e reforço musculotendíneos.

show abstract

Section: Classificationmentioning

confidence: 99%

Section: Mecanismos De Lesãounclassified

Section: Classificaçãounclassified

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Lesão muscular: Fisiopatologia, diagnóstico e tratamento

SantAnna

Pedrinelli

Hernandez

et al. 2022

Rev Bras Ortop (Sao Paulo)

View full text Add to dashboard Cite

show abstract

“…Maffulli et al (15) offered a similar grading system. Sant'Anna et al (16) provide a review of other classification systems. The above grading frameworks failed to associate various characteristics of muscle injury with the rehabilitation time.…”

Section: Introductionmentioning

confidence: 99%

Hamstring Structural Injury in Futsal Players. The Effect of Active Range of Motion (AROM) Deficit on Rehabilitation Period

Смирнова

Derinov

Glazkova

2020

Muscle Ligaments and Tendons J

View full text Add to dashboard Cite

Background. Hamstring muscle injuries are among the most common traumas occurring in athletes and football players. Thus, the rehabilitation time is crucial for their return to full athlete activity. Objective. Knee active range of motion deficit after the hamstring injury in futsal players correlates with rehabilitation time. The objective is to examine cases of hamstring structural injury in futsal players and find association between the Active Range of Motion (AROM) deficit and rehabilitation time. Methods. For this study, 200 futsal players with acute, first-time, unilateral posterior hamstring injuries were recruited, all men. All patients underwent clinical examination and ultrasonography. In 74 of 200 patients, sonography revealed no abnormalities in the musculoligamentary structures. Thereby, they were excluded from further investigation. Only 126 futsal players underwent the active range of motion testing. Injured areas were compared with the normal hamstrings in all athletes and with the control group. The AROM deficit was evaluated. The association between time to full recovery and the AROM deficit was identified. A control group (100 men) underwent examination in the same series of steps as the study group. Results. Biceps femoris was the most commonly injured muscle, making up 80% of injuries. The musculotendinous junction, proximal and distal, was involved in 91% of injury cases. Twelve athletes had an AROM deficit of 26 to 35 degrees. For them, the average length of the recovery period was 2.5 months at its minimum. Seventy or 55.5% of athletes had an AROM deficit less than 15 degrees. These athletes felt fully recovered after 3-4 weeks of rehabilitation. Conclusions: The active range of knee movement deficiency is an indicator that allows an objective prediction of rehabilitation time in futsal players.

show abstract

Novel Bioresorbable Drug-Eluting Mesh Scaffold for Therapy of Muscle Injury

Chou,

Hsu,

Lee

et al. 2024

ACS Biomater. Sci. Eng.

View full text Add to dashboard Cite

A novel bioresorbable drug-eluting polycaprolactone (PCL) mesh scaffold was developed, utilizing a solvent-cast additive manufacturing technique, to promote therapy of muscle injury. The degradation rate and mechanical properties strength of the PCL mesh were characterized after immersion in a buffer solution for different times. The in vitro release characteristics of vancomycin, ceftazidime, and lidocaine from the prepared mesh were evaluated using a highperformance liquid chromatography (HPLC) assay. In addition, the in vivo efficacy of PCL meshes for the repair of muscle injury was investigated on a rat model with histological examinations. It was found that the additively manufactured PCL meshes degraded by 13% after submission in buffered solution for four months. All PCL meshes with different pore sizes exhibited greater strength than rat muscle and survived through 10,000 cyclic loadings. Furthermore, the meshes could offer a sustained release of antibiotics and analgesics for more than 3 days in vitro. The results of this study suggest that drug-loaded PCL mesh exhibits superior ability to pure PCL mesh in terms of effectively promoting muscle repair in rat models. The histological assay also showed adequate biocompatibility of the resorbable meshes. The additively manufactured biodegradable drug-eluting meshes may be adopted in the future in humans for the therapy of muscle injuries.

show abstract

Quality assessment of muscle injury classification in sports: a systematic literature review l

Cited by 3 publications

References 12 publications

Lesão muscular: Fisiopatologia, diagnóstico e tratamento

Lesão muscular: Fisiopatologia, diagnóstico e tratamento

Hamstring Structural Injury in Futsal Players. The Effect of Active Range of Motion (AROM) Deficit on Rehabilitation Period

Novel Bioresorbable Drug-Eluting Mesh Scaffold for Therapy of Muscle Injury

Contact Info

Product

Resources

About